Phase I study of clofarabine plus Idarubicin and Clofarabine plus Idarubicin plus Cytarabine (ARA-C) in patients (PTS) with relapsed and primary refractory acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloid blast phase of chronic myeloid leukemia (CML).

被引：4

作者：

Faderl, S

Ferrajolil, A

Wierda, W

Verstovsek, S

Ravandi-Kashani, F

Garcia-Manero, G

Estey, E

Thomas, DA

Kornblau, S

Kwari, M

Gandhi, V

Kantarjian, HM

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[2] MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA

来源：

关键词：

D O I：

10.1182/blood.V104.11.1809.1809

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1809

引用

页码：501A / 501A

页数：1